CSL share price edges up as ASX climbs — what investors watch before February results
CSL shares closed 0.14% higher at A$175.53 Friday, trailing the S&P/ASX 200’s 0.48% gain. The stock remains well below its 52-week high of A$280.43 after last year’s revenue forecast cut. Investors await CSL’s half-year results on Feb. 11 for updates on guidance and the Seqirus vaccine unit. Trading volume reached about 1.07 million shares.